Apichart Panichevaluk

Learn More
BACKGROUND Amifostine has a potential role for salivary gland protection in head and neck cancer patients who had radiotherapy. MATERIAL AND METHOD Sixty-seven head and neck cancer patients were randomized to receive radiotherapy or radiotherapy plus Amifostine. The efficacy of the treatment was determined by a questionnaire evaluating dryness of mouth(More)
OBJECTIVE Phase I multicenter study defined the maximal tolerated dose (MTD), dose-limiting toxicity (DLT) and safety profile of capecitabine in combination with preoperative radiation for patients with locally advanced rectal cancer (LARC). MATERIAL AND METHOD Patients were treated with oral capecitabine (700, 800, 900, 1000, 1100 and 1200 mg/m2 twice(More)
BACKGROUND AND PURPOSE To evaluate the efficacy and the safety of WF10 as adjunct to standard treatment in the management of late hemorrhagic radiation cystitis compared to standard treatment alone. PATIENTS AND METHODS Cervical cancer patients with Grade 2 or 3 late hemorrhagic radiation cystitis, were randomized and treated with WF10 0.5 ml/kg body(More)
1. HDR Ir-192 intracavitary insertion in Foley's catheter for a boostered radiation dose to the nasopharynx is a very simple and safe technique and may increase the local control and survival of the patients. 2. Intracavitary brachytherapy should be done in all cases of NPC after the completion of external irradiation to increase local control that may lead(More)
  • 1